Charles Farthing

5.3k citations

46 papers · 4.0k indexed · 1 hit paper · h-index 22

Impact in

Virology top 0.1%
- HIV Research and Treatment
Infectious Diseases top 0.5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions

Papers in ⓘ

Virology 18
- HIV Research and Treatment 18
Infectious Diseases 21
- HIV/AIDS drug development and treatment 17
- HIV/AIDS Research and Interventions 13

Co-authors: David D. Ho (2 shared papers)Charla Andrews (1 shared paper)Yaming Cao (1 shared paper)Richard A. Koup (1 shared paper)William Borkowsky (1 shared paper)Gavin X. McLeod (1 shared paper)Jeffrey T. Safrit (1 shared paper)Calvin Cohen (4 shared papers)
Journals: AIDS (6 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (4 papers)Clinical Infectious Diseases (3 papers)The Lancet (3 papers)Journal of Medical Virology (2 papers)
Partner nations: United States United Kingdom India

In The Last Decade

Charles Farthing

46 papers receiving 3.9k citations

Hit Papers

align trajectories log scale

Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome 1994 · 2.0k citations

Peers

Countries citing papers authored by Charles Farthing

Since Specialization

Citations

This map shows the geographic impact of Charles Farthing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Farthing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Farthing more than expected).

Fields of papers citing papers by Charles Farthing

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Farthing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Farthing. The network helps show where Charles Farthing may publish in the future.

Co-authors

The 25 scholars most cited alongside Charles Farthing, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Charles Farthing Line = papers co-authored together Charles Farthing links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome Journal of Virology ·Richard A. Koup, Jeffrey T. Safrit, Yaming Cao, Charla Andrews, Gavin X. McLeod, William Borkowsky, Charles Farthing, David D. Ho Hit paper breakdown →	1994	2035
2	Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials The Lancet ·Bonaventura Clotet, Nicholas Bellos, Jean‐Michel Molina, David A. Cooper, Jean‐Christophe Goffard, Adriano Lazzarin, A. Wöhrmann, Christine Katlama, Timothy Wilkin, Richard Haubrich, Calvin Cohen, Charles Farthing, Dushyantha Jayaweera, Martin Markowitz, Peter Ruane, Sabrina Spinosa‐Guzman, Éric Lefebvre	2007	367
3	Antiviral Activity, Pharmacokinetics, and Dose Response of the HIV-1 Integrase Inhibitor GS-9137 (JTK-303) in Treatment-Naive and Treatment-Experienced Patients JAIDS Journal of Acquired Immune Deficiency Syndromes ·Edwin DeJesus, Daniel Berger, Martin Markowitz, Calvin Cohen, Trevor Hawkins, Peter Ruane, Richard Elion, Charles Farthing, Lijie Zhong, Andrew Cheng, Damian J. McColl, Brian P. Kearney	2006	223
4	PREVALENCE OF ANTIBODY TO HUMAN T-LYMPHOTROPIC VIRUS TYPE III IN AIDS AND AIDS-RISK PATIENTS IN BRITAIN The Lancet ·R. Cheingsong‐Popov, Richard Weiss, Angus Dalgleish, Richard S. Tedder, D J Jeffries, D.C. Shanson, R. Bridget Ferns, Emily Briggs, Ian Weller, S Mitton, Michael Adler, Charles Farthing, A G Lawrence, Brian Gazzard, Jan Weber, J R Harris, A J Pinching, J. Craske, J. A. J. Barbara	1984	162
5	Ritonavir and saquinavir combination therapy for the treatment of HIV infection AIDS ·D. William Cameron, Anthony J. Japour, Yi Xu, Ann Hsu, John W. Mellors, Charles Farthing, Calvin Cohen, Donald M. Poretz, Martin Markowitz, Steve Follansbee, Jonathan B. Angel, Deborah K. McMahon, David D. Ho, Viswanath Devanarayan, Richard A. Rode, Miklos Salgo, Dale J. Kempf, Richard Granneman, John M. Leonard, Eugene Sun	1999	157
6	A randomized trial assessing the impact of phenotypic resistance testing on antiretroviral therapy AIDS ·Calvin Cohen, Susan C. Hunt, Michael Sension, Charles Farthing, Marcus A. Conant, Susan Jacobson, Jeffrey P. Nadler, Werner Verbiest, Kurt Hertogs, Michael Ames, Alex R. Rinehart, Neil M.H. Graham	2002	126
7	Treatment of resistant aphthous ulceration with thalidomide in patients positive for HIV antibody. BMJ ·M Youle, J. Clarbour, Charles Farthing, Maureen Connolly, David Hawkins, R.C.D. Staughton, Brian Gazzard	1989	104
8	Idiopathic CD4+ T-Lymphocytopenia -- Immunodeficiency without Evidence of HIV Infection New England Journal of Medicine ·David D. Ho, Yunzhen Cao, Tuofu Zhu, Charles Farthing, Ning Wang, Guiling Gu, Robert T. Schooley, Eric S. Daar	1993	101
9	Skin disease in homosexual patients with Acquired Immune Deficiency Syndrome (AIDS) and lesser forms of human T cell Leukaemia Virus (HTLV III) disease Clinical and Experimental Dermatology ·Charles Farthing, R.C.D. Staughton, C M E Rowland Payne	1985	88
10	Efficacy of the Protease Inhibitors Tipranavir plus Ritonavir in Treatment-Experienced Patients: 24-Week Analysis from the RESIST-1 Trial Clinical Infectious Diseases ·Joseph Gathe, David A. Cooper, Charles Farthing, Dushyantha Jayaweera, Dorece Norris, Gerald Pierone, C. R. Steinhart, Benoît Trottier, Sharon Walmsley, Cassy Workman, Geoffrey Mukwaya, Veronika Kohlbrenner, Catherine Dohnanyi, Scott McCallister, Douglas L. Mayers, (unknown)	2006	67
11	Impact of an Educational Program on Efficacy and Adherence With a Twice-Daily Lamivudine/Zidovudine/Abacavir Regimen in Underrepresented HIV-Infected Patients JAIDS Journal of Acquired Immune Deficiency Syndromes ·M. Keith Rawlings, Melanie Thompson, Charles Farthing, Lawrence S. Brown, Joseph Racine, Robert C. Scott, Karen H. Crawford, Shirley Goodwin, Jerry M. Tolson, Vanessa C. Williams, Mark S. Shaefer	2003	64
12	The efficacy and safety of zidovudine alone or as cotherapy with acyclovir for the treatment of patients with AIDS and AIDS-related complex AIDS ·David A. Cooper, P Pehrson, Court Pedersen, Mauro Moroni, Éric Oksenhendler, Willy Rozenbaum, Nathan Clumeck, Viggo Faber, W. Stille, Bernard Hirschel, Charles Farthing, Richard Doherty, Jane Yeo	1993	63
13	Once-Daily versus Twice-Daily Lamivudine, in Combination with Zidovudine and Efavirenz, for the Treatment of Antiretroviral-Naive Adults with HIV Infection: A Randomized Equivalence Trial Clinical Infectious Diseases ·E DeJesus, Dennis McCarty, Charles Farthing, Denise Shortino, Beatriz Grinsztejn, Deborah A. Thomas, Shannon Schrader, Steve A Castillo, Michael Sension, Kevin Gough, Sarah J. Madison, (unknown)	2004	50
14	Efficacy of an Individualized Adherence Support Program with Contingent Reinforcement Among Nonadherent HIV-Positive Patients Journal of the International Association of Physicians in AIDS Care ·Marjan Javanbakht, Paul Prosser, Tim Grimes, M.C. Weinstein, Charles Farthing	2006	46
15	Response to JAIDS Journal of Acquired Immune Deficiency Syndromes ·Homayoun Khanlou, Stan G. Louie, Charles Farthing	2006	40
16	Treatment of cytomegalovirus pneumonitis with foscarnet (trisodium phosphonoformate) in patients with AIDS Journal of Medical Virology ·Charles Farthing, Michael G. Anderson, Michael Ellis, Brian Gazzard, A. C. Chañas	1987	32
17	CLINICAL FINDINGS AND SEROLOGICAL EVIDENCE OF HTLV-III INFECTION IN HOMOSEXUAL CONTACTS OF PATIENTS WITH AIDS AND PERSISTENT GENERALISED LYMPHADENOPATHY IN LONDON The Lancet ·Brian Gazzard, Charles Farthing, D.C. Shanson, A G Lawrence, Richard S. Tedder, R. Cheingsong‐Popov, Angus Dalgleish, Richard Weiss	1984	32
18	Dose-escalation, phase I/II study of azithromycin and pyrimethamine for the treatment of toxoplasmic encephalitis in AIDS AIDS ·Jeffrey M. Jacobson, Richard Hafner, Jack S. Remington, Charles Farthing, Jeanne Holden‐Wiltse, Elizabeth M. Bosler, Carol Harris, Dushyantha Jayaweera, Clemente T. Roque, Benjamin J. Luft	2001	30
19	Pilot Study of Topical Trifluridine for the Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex Disease in Patients with AIDS (ACTG 172) Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology ·Harold A. Kessler, S S Hurwitz, Charles Farthing, Constance A. Benson, Judith Feinberg, Daniel R. Kuritzkes, Thomas C. Bailey, Sharon Safrin, Roy T. Steigbigel, Sarah H. Cheeseman, George McKinley, B. Wettlaufer, Susan Owens, Thomas Nevin, Joyce A. Korvick	1996	26
20	Results of an Antiretroviral Adherence Intervention: STAR (Staying Healthy: Taking Antiretrovirals Regularly) Journal of the International Association of Physicians in AIDS Care ·Debra A. Murphy, William D. Marelich, Neil B. Rappaport, Dannie Hoffman, Charles Farthing	2007	26

About Charles Farthing

Charles Farthing is a scholar working on Virology, Infectious Diseases, Immunology, Dermatology and Epidemiology, having authored 46 papers that have together received 4.0k indexed citations. Recurring topics across this work include HIV Research and Treatment (18 papers), HIV/AIDS drug development and treatment (17 papers), HIV/AIDS Research and Interventions (13 papers), Viral-associated cancers and disorders (7 papers), Pneumocystis jirovecii pneumonia detection and treatment (6 papers), T-cell and Retrovirus Studies (5 papers), Cytomegalovirus and herpesvirus research (4 papers) and Animal Disease Management and Epidemiology (4 papers). The work is most often cited by research in Virology (3.0k citations), Infectious Diseases (1.9k citations), Immunology (1.7k citations), Epidemiology (1.1k citations) and Emergency Medicine (256 citations). Charles Farthing has collaborated with scholars based in United States, United Kingdom and India. Frequent co-authors include David D. Ho, Charla Andrews, Yaming Cao, Richard A. Koup, William Borkowsky, Gavin X. McLeod, Jeffrey T. Safrit, Calvin Cohen, Martin Markowitz and R.C.D. Staughton. Their work appears in journals such as AIDS, JAIDS Journal of Acquired Immune Deficiency Syndromes, Clinical Infectious Diseases, The Lancet and Journal of Medical Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact